Reducing Hf Hospitalization Risk: Antidiabetic Drug Classes Compared | Latest News RSS feed

Reducing Hf Hospitalization Risk: Antidiabetic Drug Classes Compared - Latest News

Incretin-based drugs were not linked to HF hospitalization compared with other oral antidiabetic drug combinations

diabetes, are incretin-based drugs ... risk for heart failure (HF) compared with combinations of other oral antidiabetic drugs? Nested case–control study, using administrative databases in Canada, a g... read more

New study says antidiabetic drug reduces risk of heart failure

The presence of diabetes already increases the risk of developing heart failure two- to four-fold, so giving drugs that can heighten the risk may really do diabetics more harm than good. Hospitalizati... read more

Certain Patients with Type 2 Diabetes Less Likely to Suffer Heart Failure While Taking New Class of Antidiabetic Drug

Patients with diabetes also face a higher risk of recurrent heart failure, compared with people without diabetes. Food and Drug Administration ... individuals using certain classes of medications, and ... read more

Looking for another news?

No increased heart failure with incretin-based drugs

Incretin-based drugs, a type of medication used to treat type 2 diabetes, do not increase the risk of being hospitalized for heart failure relative to commonly used combinations of oral anti-diabetic ... read more

Diabetes Drug Might Also Ease Heart Failure Risks

Type 2 diabetics who took Farxiga (dapagliflozin) saw their odds of hospitalization for heart failure drop by 27 percent compared to those who took ... Taking the drug did not reduce the risk of heart ... read more

Play of Chance Versus Concerns Regarding Dipeptidyl Peptidase-4 Inhibitors: Heart Failure and Diabetes

In summary, the heart failure syndrome in diabetes carries an ominous outlook, and, with an increasing number of antidiabetic drugs ... did not reduce CV events in diabetes patients. The apparent off- ... read more

Novartis' PARADIGM-HF study shows Entrest reduces cardiovascular death/hospitalization for heart failure patients with reduced ejection fraction

Novartis announced new analyses of the data from PARADIGM-HF ... compared to enalapril. Entresto is indicated in the US to reduce the risk of cardiovascular death and hospitalization for heart failure ... read more

Research in the news: Diabetes drug reduces risk of heart failure and may prevent it, study shows

But a new class of type 2 diabetes drugs (SGLT2 inhibitors) that reduce ... compared to those on placebo. They also found major significant reductions in hospitalizations for heart failure (35%); the ... read more

Is Novartis' LCZ696 "revolutionary" or just a marginal improvement?

Prior to the presentation, Wall Street's sales projections for the drug were in the vicinity ... that LCZ696 confers a 20% relative risk reduction versus enalapril for developing the study endpoints o... read more

No increased heart failure with incretin-based drugs

Canadian drug safety network provides reassuring evidence regarding risk of heart failure of anti-diabetes ... to help reduce blood sugar in patients with type 2 diabetes. Approximately 12% of these p... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us